• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Finding Gratitude in My Myeloma Experience

by | Mar 20, 2023 | Uncategorized

Source: Cure Today articles I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving. Read More

New Myeloma Therapies Are ‘A Huge Improvement for the Field’

by | Mar 17, 2023 | Uncategorized

Source: Cure Today articles Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant. Read More

Multiple Myeloma Patients Find Clear Clinical and Emotional Benefit from MRD Testing. So How Do We Increase Awareness?

by | Mar 9, 2023 | Uncategorized

Source: Cure Today articles A new survey from HealthTree Foundation and Adaptive Biotechnologies shows that patients with multiple myeloma report significant clinical and emotional benefits from MRD testing and 90% of patients who have had MRD testing would recommend...

Myeloma Disproportionately Impacts Black Patients

by | Mar 6, 2023 | Uncategorized

Source: Cure Today articles Post Content Read More

Onward in the Fight Against Multiple Myeloma

by | Mar 3, 2023 | Uncategorized

Source: Cure Today articles Multiple Myeloma Awareness Month is a time to raise awareness both locally and nationally about efforts to fight myeloma. Read More

CAR-T safe, effective for adults with multiple myeloma and renal insufficiency

by | Feb 28, 2023 | Uncategorized

Adults with advanced multiple myeloma and renal insufficiency treated with idecabtagene vicleucel achieved similar outcomes as those with normal renal function, according to retrospective study results.A single dose of the chimeric antigen receptor T-cell therapy...
« Older Entries
Next Entries »

Recent Content

  • Fixed-Dose Subcutaneous Sarclisa Combo is Non-Inferior to IV Sarclisa in R/R Myeloma
  • Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma
  • Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma
  • IVIG Supplementation Reduces Infection Risk in Patients With Multiple Myeloma Receiving Teclistamab
  • Combination induces durable responses in advanced multiple myeloma
  • Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes
  • Peroxiredoxin 6 maintains mitochondrial homeostasis and promotes tumor progression through ROS/JNK/p38 MAPK signaling pathway in multiple myeloma
  • Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
  • Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials
  • Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT